Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.

Ludvigsson J, Krisky D, Casas R, Battelino T, Castaño L, Greening J, Kordonouri O, Otonkoski T, Pozzilli P, Robert JJ, Veeze HJ, Palmer J, Samuelsson U, Elding Larsson H, Åman J, Kärdell G, Neiderud Helsingborg J, Lundström G, Albinsson E, Carlsson A, Nordvall M, Fors H, Arvidsson CG, Edvardson S, Hanås R, Larsson K, Rathsman B, Forsgren H, Desaix H, Forsander G, Nilsson NÖ, Åkesson CG, Keskinen P, Veijola R, Talvitie T, Raile K, Kapellen T, Burger W, Neu A, Engelsberger I, Heidtmann B, Bechtold S, Leslie D, Chiarelli F, Cicognani A, Chiumello G, Cerutti F, Zuccotti GV, Gomez Gila A, Rica I, Barrio R, Clemente M, López Garcia MJ, Rodriguez M, Gonzalez I, Lopez JP, Oyarzabal M, Reeser HM, Nuboer R, Stouthart P, Bratina N, Bratanic N, de Kerdanet M, Weill J, Ser N, Barat P, Bertrand AM, Carel JC, Reynaud R, Coutant R, Baron S.

N Engl J Med. 2012 Feb 2;366(5):433-42. doi: 10.1056/NEJMoa1107096.

2.

Therapy with GAD in diabetes.

Ludvigsson J.

Diabetes Metab Res Rev. 2009 May;25(4):307-15. doi: 10.1002/dmrr.941. Review.

PMID:
19267332
3.

GAD-alum immunotherapy in Type 1 diabetes mellitus.

Morales AE, Thrailkill KM.

Immunotherapy. 2011 Mar;3(3):323-32. doi: 10.2217/imt.11.9. Review.

PMID:
21395375
4.

GAD65 autoimmunity-clinical studies.

Uibo R, Lernmark A.

Adv Immunol. 2008;100:39-78. doi: 10.1016/S0065-2776(08)00803-1. Review.

PMID:
19111163
5.

GAD-alum (Diamyd)--a new concept for preservation of residual insulin secretion.

Ludvigsson J.

Expert Opin Biol Ther. 2010 May;10(5):787-99. doi: 10.1517/14712591003742920. Review.

PMID:
20230187
6.

Does immune-tolerance treatment with Alum-formulated GAD65 protect insulin-production in the pancreatic islet β cells?

Larsson HE, Lernmark A.

Hum Vaccin. 2011 Jan 1;7(1):45-9. Epub 2011 Jan 1. Review.

PMID:
21263221
7.

Vaccination against type 1 diabetes.

Larsson HE, Lernmark Å.

J Intern Med. 2011 Jun;269(6):626-35. doi: 10.1111/j.1365-2796.2011.02386.x. Review.

8.

Diamyd, an alum-formulated recombinant human GAD65 for the prevention of autoimmune diabetes.

Hinke SA.

Curr Opin Mol Ther. 2008 Oct;10(5):516-25. Review.

PMID:
18830927
9.

The role of immunomodulation therapy in autoimmune diabetes.

Ludvigsson J; Linköping Diabetes Immune Intervention Study Group..

J Diabetes Sci Technol. 2009 Mar 1;3(2):320-30. Review.

10.

2011 Update: antigen-specific therapy in type 1 diabetes.

Michels AW, von Herrath M.

Curr Opin Endocrinol Diabetes Obes. 2011 Aug;18(4):235-40. doi: 10.1097/MED.0b013e32834803ae. Review.

11.

A Swedish approach to the prevention of type 1 diabetes.

Elding Larsson H.

Pediatr Diabetes. 2016 Jul;17 Suppl 22:73-7. doi: 10.1111/pedi.12325. Review.

PMID:
27411440

Supplemental Content

Support Center